Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WELLNESS HEALTH GROUP, LLC

NPI: 1891280541 · TULSA, OK 74133 · Clinical Medical Laboratory · NPI assigned 06/26/2018

$727K
Total Medicaid Paid
37,990
Total Claims
30,066
Beneficiaries
62
Codes Billed
2019-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLOUDERMILK, DENNIS (CEO)
NPI Enumeration Date06/26/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 1,088 $29K
2020 2,759 $139K
2021 3,409 $119K
2022 10,196 $285K
2023 14,810 $95K
2024 5,728 $59K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,830 1,590 $284K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 2,656 2,504 $119K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 917 869 $84K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,558 1,093 $59K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,137 1,026 $39K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 701 566 $32K
87500 1,321 1,189 $18K
80050 General health panel 389 377 $11K
80053 Comprehensive metabolic panel 1,998 1,734 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,234 1,860 $6K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 428 373 $6K
80061 Lipid panel 1,428 1,293 $6K
87640 939 813 $6K
87150 746 640 $5K
83036 Hemoglobin; glycosylated (A1C) 1,541 1,382 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 896 776 $5K
87641 895 776 $5K
87581 830 720 $4K
87541 808 699 $3K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 13 13 $3K
87481 245 227 $2K
84481 550 476 $2K
87486 405 350 $2K
87551 195 183 $1K
86376 154 146 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 212 197 $1K
84439 732 629 $1K
84443 Thyroid stimulating hormone (TSH) 948 812 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 197 185 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 182 169 $986.91
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 782 677 $946.75
80048 Basic metabolic panel (calcium, ionized) 228 204 $714.24
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 329 280 $543.69
84134 61 54 $480.26
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 120 80 $407.57
36415 Collection of venous blood by venipuncture 2,035 1,565 $327.56
82728 166 137 $290.88
80177 27 27 $259.38
83550 260 213 $202.99
83880 14 12 $174.60
81003 318 286 $168.60
80164 25 24 $144.48
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 991 720 $136.91
82607 458 366 $113.43
83735 461 373 $110.10
87086 Culture, bacterial; quantitative colony count, urine 157 129 $95.12
87511 56 55 $70.18
86140 16 14 $69.15
85652 28 26 $64.80
83540 54 42 $46.00
87186 86 69 $39.41
87077 86 69 $36.86
87653 156 144 $35.09
82746 120 96 $29.40
80076 12 12 $15.44
84100 192 150 $9.39
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 578 490 $7.82
83719 14 14 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 15 15 $0.00
81405 31 28 $0.00
83695 14 14 $0.00
82248 15 14 $0.00